홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Alendronate Sodium

HCID 23681107
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
121268-17-5
표준 SMILES
NCCCC(O)(P(=O)([O-])O)P(=O)(O)O.O.O.O.[Na+]
InChIKey
DCSBSVSZJRSITC-UHFFFAOYSA-M
분자식
C4H18NNaO10P2
평균 분자량
325.12 g/mol
단동위원소 질량
325.03036332

개요

Alendronate sodium trihydrate is a hydride that is the trihydrate of alendronate sodium. It has a role as an EC 2.5.1.1 (dimethylallyltranstransferase) inhibitor and a bone density conservation agent. It is a hydrate and an organic sodium salt. It contains an alendronate(1-).

이름 및 식별자

우선 이름
Alendronate Sodium
IUPAC
sodium;(4-amino-1-hydroxy-1-phosphonobutyl)-hydroxyphosphinate;trihydrate
영어명
Alendronate sodium trihydrate
분자식
C4H13NO7P2.3H2O.Na
분자량
326.13

이름 및 동의어

Alendronate sodium trihydrateALENDRONATE SODIUMAdronatAlendrosSODIUM ALENDRONATE TRIHYDRATEAdrovanceSodium alendronateVantavoDTXSID7047801Alendronic acid monosodium salt trihydrate2UY4M2U3RAFosavance
이름 더 보기
SodiuM Alendronate HydrateFosamaxBifosaNeoBonFosamsx
OnclastPhosphonic acid, (4-amino-1-hydroxybutylidene)bis-, monosodium salt, trihydrateG-704,650sodium hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate trihydrateAlendronate (as sodium)MK-217Monosodium (4-amino-1-hydroxybutylidene)bisphosphonate trihydrateCHEBI:2566

데이터베이스 식별자

CAS
121268-17-5
PubChem CID
23681107
DTXSID
DTXSID7047801
ChEMBL
CHEMBL2367465、CHEMBL675
ChEBI
CHEBI:2566
UNII
2UY4M2U3RA
EC Number
601-766-4、950-815-9

물성

구조 계산 물성

극성 표면적
167 Ų
수소 결합 공여자 수
8
수소 결합 수용자 수
11
회전 가능 결합 수
5
무거운 원자 수
18
형식 전하
0
복잡도
293

실험 및 물리화학적 성질

Human Drugs · 4건

FDA approved drugs -> Active ingredient

EMA approved medicines: Human medicine

EMA approved medicines: Human medicine

FDA approved drugs -> Active ingredient

물리화학적 성질

녹는점
245 °C · 245°C
저장 조건
-20 °C · -20°C
용해도
10 mg/mL · 물, 이중 증류: 10mg/mL
물리적 상태
고체
색상
하얀색
수용성
10 mg/ml의 · 10mg/ml의 물에 용해됨
Merck
14 · 14,229
안정성
냉동고에 보관
InChI
InChI=1S/C4H13NO7P2.Na.3H2O/c5-3-1-2-4(6,13(7,8)9)14(10,11)12;;;;/h6H,1-3,5H2,(H2,7,8,9)(H2,10,11,12);;3*1H2/q;+1;;;/p-1
InChIKey
NKENDYHBVCKCNL-UHFFFAOYSA-M
SMILES
C(O)(CCCN)(P([O-])(=O)O)P(=O)(O)O.[Na+].O.O.O

화학적 성질

White Crystalline Solid

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 6건

This chemical does not meet GHS hazard criteria for 1.8% (2 of 110) of reports.

Danger

H302 (98.2%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P260, P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P354+P338, P317, P318, P319, P321, P330, P332+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 110 reports by companies from 11 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Warning

유해성 정보

Hazard Classes and Categories · 2건

Acute Tox. 4 (98.2%)

Acute Tox. 4 (100%)

독성 정보

Exposure Routes · 1건

Relative to an intravenous (IV) reference dose, the mean oral bioavailability of alendronate in women was 0.7% for doses ranging from 5 to 40 mg when administered after an overnight fast and two hours before a standardized breakfast. Oral bioavailability of the 10 mg tablet in men (0.59%) was similar to that in women (0.78%) when administered after an overnight fast and 2 hours before breakfast.

Toxicity Summary · 1건

The action of Alendronate on bone tissue is based partly on its affinity for hydroxyapatite, which is part of the mineral matrix of bone. Alendronate also targets farnesyl pyrophosphate (FPP) synthase. Nitrogen-containing bisphosphonates (such as pamidronate, alendronate, risedronate, ibandronate and zoledronate) appear to act as analogues of isoprenoid diphosphate lipids, thereby inhibiting FPP synthase, an enzyme in the mevalonate pathway. Inhibition of this enzyme in osteoclasts prevents the biosynthesis of isoprenoid lipids (FPP and GGPP) that are essential for the post-translational farnesylation and geranylgeranylation of small GTPase signalling proteins. This activity inhibits osteoclast activity and reduces bone resorption and turnover. In postmenopausal women, it reduces the elevated rate of bone turnover, leading to, on average, a net gain in bone mass.

Signs and SymptomsAlendronate can damage the esophagus both by toxicity from the medication itself and by nonspecific irritation secondary to contact between the pill and the esophageal mucosa, similar to other cases of "pill esophagitis."
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 6건

Drug Induced Liver Injury Rank (DILIrank 2.0)

Alendronate sodium

vLess-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

안전 데이터

wgk
3
rtecs
SZ6523500
HS 번호
29310095
risk_code
22-36/37/38
hazard_code
Xn,Xi
safety_code
26-36-60
기존화학 물질
2014-3-6031
Hazard Classifications
Acute Tox. 4 Oral
스토리지 클래스
11 - Combustible Solids

화학 및 산업

약리 정보

Metabolism/Metabolites · 1건

There is no evidence that alendronate is metabolized in humans or animals. Route of Elimination: Following a single IV dose of [14C]alendronate, approximately 50% of the radioactivity was excreted in the urine within 72 hours and little or no radioactivity was recovered in the feces. Half Life: >10 years

FDA Pharmacological Classification · 4건

ALENDRONATE SODIUM

Diphosphonates [CS]; Bisphosphonate [EPC]

ALENDRONATE SODIUM TABLET

Bisphosphonate [EPC]; Diphosphonates [CS]

MeSH Pharmacological ClassificationAgents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS.

용도 및 제조

UsesFor the treatment and prevention of osteoporosis in women and Paget's disease of bone in both men and women.
응용 분야 · 2건

용도Alendronate sodium trihydrate is used as a bone resorption inhibitor, farnesyl diphosphate synthase inhibitor and CD45 protein tyrosine phosphatase inhibitor. A robust inhibitor of bone resorption that induces apoptosis. Alendronate inhibits the migration and invasion of PC-3 cells (sc-2220) by interfering with the mevalonate pathway. Additionally, Alendronate, Sodium Salt is an inhibitor of CD45RC and MMP.

일반 설명Alendronate Sodium, an aminobisphosphonate compound, has been effectively used for the treatment of osteolysis, Paget′s disease and osteoporosis.

상·하류 제품 정보

상류 원료

삼염화 인감마-아미노-N-부티르 산포스포로우수 산Alendronic acid2-피롤리디논수산화나트륨탄산나트륨(경회)

추가 설명

정의ChEBI: A hydride that is the trihydrate of alendronate sodium

관련 반응

8건
반응 기록 만들기
HRID 128913 반응식
HRID 128913반응물로
HRID 651848 반응식
HRID 651848반응물로
HRID 871804 반응식
HRID 871804반응물로
HRID 871805 반응식
HRID 871805반응물로
HRID 871806 반응식
HRID 871806반응물로
HRID 1062844 반응식
HRID 1062844반응물로
HRID 1676015 반응식
HRID 1676015생성물로
HRID 2122077 반응식
HRID 2122077반응물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트